| zosyn vs cefepime | 0.04 | 0.2 | 2816 | 17 | 76 |
| zosyn vs cefepime coverage | 0.09 | 0.6 | 346 | 26 | 14 |
| zosyn vs cefepime flagyl | 0.24 | 0.4 | 5827 | 24 | 98 |
| zosyn vs cefepime aki | 1.28 | 0.1 | 5153 | 21 | 21 |
| zosyn vs cefepime for pseudomonas coverage | 1.6 | 0.8 | 7992 | 42 | 82 |
| zosyn vs cefepime study | 2 | 0.7 | 1271 | 23 | 92 |
| zosyn vs cefepime trial | 1.48 | 0.7 | 1177 | 23 | 34 |
| zosyn vs cefepime for uti | 0.03 | 0.8 | 1031 | 25 | 95 |
| zosyn vs cefepime nephrotoxicity | 1.84 | 0.9 | 2365 | 32 | 8 |
| zosyn vs cefepime cns penetration | 1.03 | 0.3 | 4929 | 33 | 64 |
| zosyn vs cefepime neutropenic fever | 1.35 | 1 | 7884 | 35 | 82 |
| vanc zosyn vs vanc cefepime | 0.55 | 0.5 | 904 | 27 | 10 |
| cefepime vs zosyn renal toxicity | 2 | 0.7 | 7315 | 32 | 42 |
| cefepime vs zosyn jama | 0.26 | 0.7 | 7225 | 22 | 37 |
| cefepime vs zosyn anaerobic coverage | 0.61 | 0.7 | 1070 | 36 | 13 |
